DK1603533T3 - Opioidfremföringssystem - Google Patents

Opioidfremföringssystem

Info

Publication number
DK1603533T3
DK1603533T3 DK04715861T DK04715861T DK1603533T3 DK 1603533 T3 DK1603533 T3 DK 1603533T3 DK 04715861 T DK04715861 T DK 04715861T DK 04715861 T DK04715861 T DK 04715861T DK 1603533 T3 DK1603533 T3 DK 1603533T3
Authority
DK
Denmark
Prior art keywords
opioid
administration
formulation
pulmonary
delivery system
Prior art date
Application number
DK04715861T
Other languages
English (en)
Inventor
Orlando Ricardo Hung
Steven Louis Shafer
Diana Helen Pliura
Original Assignee
Ym Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ym Biosciences Inc filed Critical Ym Biosciences Inc
Application granted granted Critical
Publication of DK1603533T3 publication Critical patent/DK1603533T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4748Quinolines; Isoquinolines forming part of bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Paper (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK04715861T 2003-02-28 2004-03-01 Opioidfremföringssystem DK1603533T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45033303P 2003-02-28 2003-02-28
PCT/CA2004/000303 WO2004075879A1 (en) 2003-02-28 2004-03-01 Opioid delivery system

Publications (1)

Publication Number Publication Date
DK1603533T3 true DK1603533T3 (da) 2009-08-17

Family

ID=32927636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04715861T DK1603533T3 (da) 2003-02-28 2004-03-01 Opioidfremföringssystem

Country Status (20)

Country Link
EP (1) EP1603533B1 (da)
JP (1) JP2006519185A (da)
KR (1) KR20050114221A (da)
CN (1) CN1780605A (da)
AT (1) ATE428402T1 (da)
AU (1) AU2004216550B2 (da)
BR (1) BRPI0408059A (da)
CA (1) CA2556629A1 (da)
CY (1) CY1109215T1 (da)
DE (1) DE602004020597D1 (da)
DK (1) DK1603533T3 (da)
ES (1) ES2325834T3 (da)
HK (1) HK1084341A1 (da)
IL (1) IL177764A0 (da)
MX (1) MXPA05009179A (da)
NZ (1) NZ542005A (da)
PT (1) PT1603533E (da)
RU (1) RU2362559C2 (da)
WO (1) WO2004075879A1 (da)
ZA (1) ZA200607418B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2039360A1 (en) * 2007-09-19 2009-03-25 Euro-Celtique S.A. Non-invasive direct delivery of opioids to the central nervous system
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
KR101298303B1 (ko) * 2010-04-27 2013-08-20 울산대학교 산학협력단 약물의 약동-약력학적 모델링을 위한 통합 분석 시스템
DE102012009617B4 (de) 2012-05-15 2020-03-26 Drägerwerk AG & Co. KGaA Datenverarbeitungseinrichtung für eine Anästhesievorrichtung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
WO1995031182A1 (en) * 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
ES2207867T3 (es) * 1998-12-11 2004-06-01 Pharmachemie B.V. Preparacion farmaceutica para inhalacion de un opioide.
JP2005503425A (ja) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device

Also Published As

Publication number Publication date
BRPI0408059A (pt) 2006-02-14
DE602004020597D1 (de) 2009-05-28
NZ542005A (en) 2009-05-31
IL177764A0 (en) 2007-03-08
RU2005130166A (ru) 2006-06-10
RU2362559C2 (ru) 2009-07-27
CN1780605A (zh) 2006-05-31
KR20050114221A (ko) 2005-12-05
WO2004075879A1 (en) 2004-09-10
MXPA05009179A (es) 2006-03-08
ZA200607418B (en) 2008-01-30
EP1603533B1 (en) 2009-04-15
ATE428402T1 (de) 2009-05-15
CA2556629A1 (en) 2004-09-10
EP1603533A1 (en) 2005-12-14
HK1084341A1 (en) 2006-07-28
JP2006519185A (ja) 2006-08-24
AU2004216550B2 (en) 2010-06-03
CY1109215T1 (el) 2014-07-02
PT1603533E (pt) 2009-07-23
AU2004216550A1 (en) 2004-09-10
ES2325834T3 (es) 2009-09-21

Similar Documents

Publication Publication Date Title
SE0201669D0 (sv) New formulation and use thereof
DE60030844D1 (de) Kombinationen von formoterol und tiotropium-salz
IT1317846B1 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
IL176449A0 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
NO20065904L (no) Terapeutiske forbindelser
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
ATE398441T1 (de) Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
CY1109215T1 (el) Συστημα χορηγησης οπιοειδους
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
MXPA06003122A (es) Composiciones farmaceuticas y procedimientos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina d y un agonista/antagonista de estrogenos.
TW200500070A (en) Method of improved diuresis in individuals with impaired renal function
GEP201606538B (en) Preoperative treatment of post operative pain
NO20064463L (no) Opioid leveringssystem
BRPI0418582A (pt) sistema de administração de opióides
TW200500085A (en) Sustained-release pharmaceutical composition for lung administration
ATE446759T1 (de) Verwendung von oxcarbazepin zur verbesserung des schlafes bei patienten die an chronischem schmerz leiden
SE9904424D0 (sv) Use of interleukin-6 in combination with leptin in treatment of obesity